Literature DB >> 19786128

Papillomavirus interaction with cellular chromatin.

Jianxin You1.   

Abstract

High-risk human papillomavirus (HPV) infection is the primary risk factor for cervical cancer. HPVs establish persistent infection by maintaining their genomes as extrachromosomal elements (episomes) that replicate along with host DNA in infected cells. The productive life cycle of HPV is intimately tied to the differentiation program of host squamous epithelium. This review examines the involvement of host chromatin in multiple aspects of the papillomavirus life cycle and the malignant progression of infected host cells. Papillomavirus utilizes host mitotic chromosomes as vehicles for transmitting its genetic materials across the cell cycle. By hitchhiking on host mitotic chromosomes, the virus ensures accurate segregation of the replicated viral episomes to the daughter cells during host cell division. This strategy allows persistent maintenance of the viral episome in the infected cells. In the meantime, the virus subverts the host chromatin-remodeling factors to promote viral transcription and efficient propagation of viral genomes. By associating with the host chromatin, papillomavirus redirects the normal cellular control of chromatin to create a cellular environment conducive to both its own survival and malignant progression of host cells. Comprehensive understanding of HPV-host chromatin interaction will offer new insights into the HPV life cycle as well as chromatin regulation. This virus-host interaction will also provide a paradigm for investigating other episomal DNA tumor viruses that share a similar mechanism for interacting with host chromatin. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19786128      PMCID: PMC2839008          DOI: 10.1016/j.bbagrm.2009.09.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  106 in total

Review 1.  Brd4: tethering, segregation and beyond.

Authors:  Alison A McBride; Maria G McPhillips; Jaquelline G Oliveira
Journal:  Trends Microbiol       Date:  2004-12       Impact factor: 17.079

2.  Properties of intracellular bovine papillomavirus chromatin.

Authors:  F Rösl; W Waldeck; H Zentgraf; G Sauer
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

3.  Regulation of aurora B expression by the bromodomain protein Brd4.

Authors:  Jianxin You; Qing Li; Chong Wu; Jina Kim; Matthias Ottinger; Peter M Howley
Journal:  Mol Cell Biol       Date:  2009-07-13       Impact factor: 4.272

Review 4.  Papillomavirus DNA replication - from initiation to genomic instability.

Authors:  Meelis Kadaja; Toomas Silla; Ene Ustav; Mart Ustav
Journal:  Virology       Date:  2009-01-13       Impact factor: 3.616

5.  Human papillomavirus E7 protein deregulates mitosis via an association with nuclear mitotic apparatus protein 1.

Authors:  Christine L Nguyen; Karl Münger
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

6.  Chromatin-like structures obtained after alkaline disruption of bovine and human papillomaviruses.

Authors:  M Favre; F Breitburd; O Croissant; G Orth
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

7.  Papillomavirus E2 proteins and the host BRD4 protein associate with transcriptionally active cellular chromatin.

Authors:  Moon Kyoo Jang; Deukwoo Kwon; Alison A McBride
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

8.  Isolation of episomal bovine papillomavirus chromatin and identification of a DNase I-hypersensitive region.

Authors:  F Rösl; W Waldeck; G Sauer
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

9.  Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences.

Authors:  M F Law; D R Lowy; I Dvoretzky; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

10.  The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region.

Authors:  F Thierry; M Yaniv
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

View more
  23 in total

1.  BET bromodomain inhibitors show anti-papillomavirus activity in vitro and block CRPV wart growth in vivo.

Authors:  Mary A Morse; Karla K Balogh; Sarah A Brendle; Colin A Campbell; Mao X Chen; Rebecca C Furze; Isobel L Harada; Ian D Holyer; Umesh Kumar; Kevin Lee; Rab K Prinjha; Martin Rüdiger; Jonathan T Seal; Simon Taylor; Jason Witherington; Neil D Christensen
Journal:  Antiviral Res       Date:  2018-04-11       Impact factor: 5.970

2.  The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters.

Authors:  Irene Lo Cigno; Marco De Andrea; Cinzia Borgogna; Silvia Albertini; Manuela M Landini; Alberto Peretti; Karen E Johnson; Bala Chandran; Santo Landolfo; Marisa Gariglio
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

3.  Histone deacetylase inhibition activates transgene expression from integration-defective lentiviral vectors in dividing and non-dividing cells.

Authors:  Laetitia P L Pelascini; Josephine M Janssen; Manuel A F V Gonçalves
Journal:  Hum Gene Ther       Date:  2012-12-11       Impact factor: 5.695

4.  Acetylation of E2 by P300 Mediates Topoisomerase Entry at the Papillomavirus Replicon.

Authors:  Yanique Thomas; Elliot J Androphy
Journal:  J Virol       Date:  2019-03-21       Impact factor: 5.103

5.  BRD4S interacts with viral E2 protein to limit human papillomavirus late transcription.

Authors:  A Yigitliler; J Renner; C Simon; M Schneider; F Stubenrauch; T Iftner
Journal:  J Virol       Date:  2021-03-17       Impact factor: 5.103

Review 6.  Snapshots: chromatin control of viral infection.

Authors:  David M Knipe; Paul M Lieberman; Jae U Jung; Alison A McBride; Kevin V Morris; Melanie Ott; David Margolis; Amelia Nieto; Michael Nevels; Robin J Parks; Thomas M Kristie
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

7.  Targeting the JMJD2 histone demethylases to epigenetically control herpesvirus infection and reactivation from latency.

Authors:  Yu Liang; Jodi L Vogel; Jesse H Arbuckle; Ganesha Rai; Ajit Jadhav; Anton Simeonov; David J Maloney; Thomas M Kristie
Journal:  Sci Transl Med       Date:  2013-01-09       Impact factor: 17.956

Review 8.  Therapeutics Targeting Protein Acetylation Perturb Latency of Human Viruses.

Authors:  Ryan J Conrad; Melanie Ott
Journal:  ACS Chem Biol       Date:  2016-02-15       Impact factor: 5.100

9.  Non-random integration of the HPV genome in cervical cancer.

Authors:  Martina Schmitz; Corina Driesch; Lars Jansen; Ingo B Runnebaum; Matthias Dürst
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

10.  A novel selective LSD1/KDM1A inhibitor epigenetically blocks herpes simplex virus lytic replication and reactivation from latency.

Authors:  Yu Liang; Debra Quenelle; Jodi L Vogel; Cristina Mascaro; Alberto Ortega; Thomas M Kristie
Journal:  mBio       Date:  2013-02-05       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.